Main Article Content
Abstract
Pulmonary lymphangitis carcinomatosa (PLC) is a distinctive pattern of metastatic spread through the pulmonary lymphatic channels and is commonly associated with breast carcinoma. We present a case highlighting characteristic breast and lung imaging findings emphasizing the radiologist’s role in early diagnosis.
Lymphangitis carcinomatosa accounts for a minority of pulmonary metastases but carries significant prognostic implications.[1] Breast carcinoma is among the most frequent primary malignancies associated with this condition. Tumour infiltration of pulmonary lymphatic channels leads to characteristic interstitial lung changes, often mimicking pulmonary edema or interstitial lung disease.[2] The 40-49 years age group is most commonly affected.[3] In 46% of patients respiratory symptoms are the initial presentation of the underlying carcinoma. The most common underlying primary tumours are breast (33%), stomach (29%) and lung cancers (17%). Approximately 50% die within 3 months of their first respiratory symptoms, but those with a primary prostatic carcinoma may have good remission with adjuvant hormonal therapy.
Clinical, radiographic, and physiological features of drug-induced and radiation-induced pulmonary injury are often difficult to distinguish from other causes of pulmonary infiltrates (e.g., infections, pulmonary edema, alveolar hemorrhage, etc.).[4] Fiberoptic bronchoscopy with bronchoalveolar lavage (BAL) is essential to exclude infectious etiologies. In some cases, surgical lung biopsies are required to establish a specific etiological diagnosis.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
- Johkoh T, Ikezoe J, Tomiyama N, et al. CT findings in lymphangitic carcinomatosis of the lung: correlation with histologic findings and pulmonary function tests. AJR Am J Roentgenol 1992;158(6):1217-22. DOI: https://doi.org/10.2214/ajr.158.6.1590110
- Munk PL, Müller NL, Miller RR, et al. Pulmonary lymphangitic carcinomatosis: CT and pathologic findings. Radiology 1988;166(3):705-9. DOI: https://doi.org/10.1148/radiology.166.3.3340765
- Bruce DM, Heys SD, Eremin O. Lymphangitis carcinomatosa: a literature review. J R Coll Surg Edinb 1996;41(1):7-13.
- Rossi SE, Erasmus JJ, McAdams HP, et al. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 2000;20(5):1245-59. DOI: https://doi.org/10.1148/radiographics.20.5.g00se081245
- Fumet JD, Wickre M, Jacquot JP, et al. Successfully treatment by eribulin in visceral crisis: a case of lymphangitic carcinomatosis from metastatic breast cancer. BMC Cancer 2018;18(1):839. DOI: https://doi.org/10.1186/s12885-018-4725-7
References
Johkoh T, Ikezoe J, Tomiyama N, et al. CT findings in lymphangitic carcinomatosis of the lung: correlation with histologic findings and pulmonary function tests. AJR Am J Roentgenol 1992;158(6):1217-22. DOI: https://doi.org/10.2214/ajr.158.6.1590110
Munk PL, Müller NL, Miller RR, et al. Pulmonary lymphangitic carcinomatosis: CT and pathologic findings. Radiology 1988;166(3):705-9. DOI: https://doi.org/10.1148/radiology.166.3.3340765
Bruce DM, Heys SD, Eremin O. Lymphangitis carcinomatosa: a literature review. J R Coll Surg Edinb 1996;41(1):7-13.
Rossi SE, Erasmus JJ, McAdams HP, et al. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 2000;20(5):1245-59. DOI: https://doi.org/10.1148/radiographics.20.5.g00se081245
Fumet JD, Wickre M, Jacquot JP, et al. Successfully treatment by eribulin in visceral crisis: a case of lymphangitic carcinomatosis from metastatic breast cancer. BMC Cancer 2018;18(1):839. DOI: https://doi.org/10.1186/s12885-018-4725-7